Retrospective analysis finds lower transfusion requirements improve survival in severe aplastic anemia patients post-HSCT, suggesting better outcomes with fewer transfusions.
Key Points
Group A's overall survival rate reached 84.0% compared to 60.0% in Group B, indicating transfusion burden significantly affects outcomes.
Graft failure was markedly lower in the group with fewer transfusions, 4.0% compared to 20.0%, emphasizing the impact of transfusion dependency.
Observational study assessed 84 patients diagnosed with severe aplastic anemia who underwent hematopoietic stem cell transplantation.
Iron overload and alloimmunization rates were also significantly lower in patients with reduced transfusion needs, highlighting areas for better management.